What Patients Need to Know About Lung Cancer Research in the Era of COVID-19


The newest episode of Lung Cancer Considered, the IASLC's official podcast program, features patient advocates and lung cancer researchers on what patients need to know about lung cancer research in the era of COVID-19. This episode features a conversation between Janet Freeman-Daily, writer, lung cancer patient, advocate and Twitter chat moderator of the Lung Cancer Social Media chat (#LCSMchat); Jill Feldman, lung cancer advocate and patient; Dr. Alice Berger, assistant professor of human biology at the Fred Hutchinson Cancer Research Center; Dr. Christine Lovly, associate professor of medicine, division of Hematology and Oncology and Ingram Associate Professor of Cancer Research at Vanderbilt University Medical Center; Dr. Brendon Stiles, associate professor of cardiothoracic surgery at Weill Cornell Medical College, Cornell University, and the associate attending cardiothoracic surgeon at New York Presbyterian Hospital; Dr. Amy Moore has experience as a cancer researcher as director of science and research at the GO2 Foundation for Lung Cancer; Dr Upal Basu Roy also has experience as a cancer researcher as vice president of research at LUNGevity Foundation; and Dr Jan Baranski, vice president of scientific and patient programs for the Lung Cancer Research Foundation.

Janet Freeman-Daily

MS, Eng

Lung Cancer Survivor
Lung Cancer Social Media Chat
Jill Feldman
Jill Feldman
EGFR Resisters
Dr. Alice Berger
Assistant Professor
Fred Hutchinson Cancer Research Center
Dr. Christine Lovly
Associate Professor of Medicine
Vanderbilt University Medical Center
Dr. Brendon Stiles
Associate Professor
Weill Cornell Medical College, Cornell University
Member Story: Dr. Amy Moore
Amy Moore


VP, Global Engagement and Patient Partnerships
LUNGevity Foundation
Upal Basu Roy
Upal Basu Roy


Executive Director of Research
LUNGevity Foundation

Other Podcast

Lung Cancer Considered Virtual Tumor Board: EGFR
Lung Cancer Considered Breakthrough Therapies
Lung Cancer Considered LALCA 2021 Highlights